M/20/020 - Arthopoda (Orpea)/Brindley [2020] IECompA m20020 (6 August 2020)

The Commission determined that the proposed acquisition would not substantially lessen competition in any market for goods or services in the State and therefore cleared the transaction at Phase 1.

Parties: Acquirer: Arthopoda Limited; Indirect Owner of Acquirer: Orpea S.A.; Target: Brindley Healthcare Limited
Jurisdiction: Ireland
Judgment Date: 06 August 2020
Procedural Posture: Merger Notification / Phase 1 Clearance
Outcome: Cleared
Legal Topics: Merger Control, Joint Control Acquisition, Healthcare Sector Mergers

Competition Law Merger Control Joint Control Acquisition Healthcare Sector Mergers

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 2 Authorities cited 1 Party arguments 2 Amounts and remedies 1

Parties

Arthopoda Limited

Acquirer

Orpea S.A.

Indirect Owner of Acquirer

Brindley Healthcare Limited

Target

Procedural Posture

Merger Notification / Phase 1 Clearance

Legal Issues

1 Whether the proposed acquisition of joint control by Arthopoda Limited (indirectly owned by Orpea S.A.) of Brindley Healthcare Limited raises competition concerns in the State.

Ratio Decidendi

The Commission determined that the proposed acquisition would not substantially lessen competition in any market for goods or services in the State and therefore cleared the transaction at Phase 1.

Court Disposition

Cleared

Orders

The proposed acquisition by Arthopoda Limited of a 50% shareholding in and joint control of Brindley Healthcare Limited is cleared.